Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Oncolytic Virus Therapy Market Size Analysis from 2022 to 2027

1.5.1 Global Oncolytic Virus Therapy Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Oncolytic Virus Therapy Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Oncolytic Virus Therapy Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Oncolytic Virus Therapy Industry Impact

Chapter 2 Global Oncolytic Virus Therapy Competition by Types, Applications, and Top Regions and Countries

2.1 Global Oncolytic Virus Therapy (Volume and Value) by Type

2.1.1 Global Oncolytic Virus Therapy Consumption and Market Share by Type (2016-2021)

2.1.2 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2016-2021)

2.2 Global Oncolytic Virus Therapy (Volume and Value) by Application

2.2.1 Global Oncolytic Virus Therapy Consumption and Market Share by Application (2016-2021)

2.2.2 Global Oncolytic Virus Therapy Revenue and Market Share by Application (2016-2021)

2.3 Global Oncolytic Virus Therapy (Volume and Value) by Regions

2.3.1 Global Oncolytic Virus Therapy Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Oncolytic Virus Therapy Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Oncolytic Virus Therapy Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Oncolytic Virus Therapy Consumption by Regions (2016-2021)

4.2 North America Oncolytic Virus Therapy Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Oncolytic Virus Therapy Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Oncolytic Virus Therapy Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Oncolytic Virus Therapy Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Oncolytic Virus Therapy Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Oncolytic Virus Therapy Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Oncolytic Virus Therapy Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Oncolytic Virus Therapy Sales, Consumption, Export, Import (2016-2021)

4.10 South America Oncolytic Virus Therapy Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Oncolytic Virus Therapy Market Analysis

5.1 North America Oncolytic Virus Therapy Consumption and Value Analysis

5.1.1 North America Oncolytic Virus Therapy Market Under COVID-19

5.2 North America Oncolytic Virus Therapy Consumption Volume by Types

5.3 North America Oncolytic Virus Therapy Consumption Structure by Application

5.4 North America Oncolytic Virus Therapy Consumption by Top Countries

5.4.1 United States Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

5.4.2 Canada Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

5.4.3 Mexico Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

Chapter 6 East Asia Oncolytic Virus Therapy Market Analysis

6.1 East Asia Oncolytic Virus Therapy Consumption and Value Analysis

6.1.1 East Asia Oncolytic Virus Therapy Market Under COVID-19

6.2 East Asia Oncolytic Virus Therapy Consumption Volume by Types

6.3 East Asia Oncolytic Virus Therapy Consumption Structure by Application

6.4 East Asia Oncolytic Virus Therapy Consumption by Top Countries

6.4.1 China Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

6.4.2 Japan Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

6.4.3 South Korea Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

Chapter 7 Europe Oncolytic Virus Therapy Market Analysis

7.1 Europe Oncolytic Virus Therapy Consumption and Value Analysis

7.1.1 Europe Oncolytic Virus Therapy Market Under COVID-19

7.2 Europe Oncolytic Virus Therapy Consumption Volume by Types

7.3 Europe Oncolytic Virus Therapy Consumption Structure by Application

7.4 Europe Oncolytic Virus Therapy Consumption by Top Countries

7.4.1 Germany Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

7.4.2 UK Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

7.4.3 France Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

7.4.4 Italy Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

7.4.5 Russia Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

7.4.6 Spain Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

7.4.7 Netherlands Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

7.4.8 Switzerland Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

7.4.9 Poland Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

Chapter 8 South Asia Oncolytic Virus Therapy Market Analysis

8.1 South Asia Oncolytic Virus Therapy Consumption and Value Analysis

8.1.1 South Asia Oncolytic Virus Therapy Market Under COVID-19

8.2 South Asia Oncolytic Virus Therapy Consumption Volume by Types

8.3 South Asia Oncolytic Virus Therapy Consumption Structure by Application

8.4 South Asia Oncolytic Virus Therapy Consumption by Top Countries

8.4.1 India Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

8.4.2 Pakistan Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Oncolytic Virus Therapy Market Analysis

9.1 Southeast Asia Oncolytic Virus Therapy Consumption and Value Analysis

9.1.1 Southeast Asia Oncolytic Virus Therapy Market Under COVID-19

9.2 Southeast Asia Oncolytic Virus Therapy Consumption Volume by Types

9.3 Southeast Asia Oncolytic Virus Therapy Consumption Structure by Application

9.4 Southeast Asia Oncolytic Virus Therapy Consumption by Top Countries

9.4.1 Indonesia Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

9.4.2 Thailand Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

9.4.3 Singapore Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

9.4.4 Malaysia Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

9.4.5 Philippines Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

9.4.6 Vietnam Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

9.4.7 Myanmar Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

Chapter 10 Middle East Oncolytic Virus Therapy Market Analysis

10.1 Middle East Oncolytic Virus Therapy Consumption and Value Analysis

10.1.1 Middle East Oncolytic Virus Therapy Market Under COVID-19

10.2 Middle East Oncolytic Virus Therapy Consumption Volume by Types

10.3 Middle East Oncolytic Virus Therapy Consumption Structure by Application

10.4 Middle East Oncolytic Virus Therapy Consumption by Top Countries

10.4.1 Turkey Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

10.4.3 Iran Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

10.4.5 Israel Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

10.4.6 Iraq Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

10.4.7 Qatar Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

10.4.8 Kuwait Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

10.4.9 Oman Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

Chapter 11 Africa Oncolytic Virus Therapy Market Analysis

11.1 Africa Oncolytic Virus Therapy Consumption and Value Analysis

11.1.1 Africa Oncolytic Virus Therapy Market Under COVID-19

11.2 Africa Oncolytic Virus Therapy Consumption Volume by Types

11.3 Africa Oncolytic Virus Therapy Consumption Structure by Application

11.4 Africa Oncolytic Virus Therapy Consumption by Top Countries

11.4.1 Nigeria Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

11.4.2 South Africa Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

11.4.3 Egypt Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

11.4.4 Algeria Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

11.4.5 Morocco Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

Chapter 12 Oceania Oncolytic Virus Therapy Market Analysis

12.1 Oceania Oncolytic Virus Therapy Consumption and Value Analysis

12.2 Oceania Oncolytic Virus Therapy Consumption Volume by Types

12.3 Oceania Oncolytic Virus Therapy Consumption Structure by Application

12.4 Oceania Oncolytic Virus Therapy Consumption by Top Countries

12.4.1 Australia Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

12.4.2 New Zealand Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

Chapter 13 South America Oncolytic Virus Therapy Market Analysis

13.1 South America Oncolytic Virus Therapy Consumption and Value Analysis

13.1.1 South America Oncolytic Virus Therapy Market Under COVID-19

13.2 South America Oncolytic Virus Therapy Consumption Volume by Types

13.3 South America Oncolytic Virus Therapy Consumption Structure by Application

13.4 South America Oncolytic Virus Therapy Consumption Volume by Major Countries

13.4.1 Brazil Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

13.4.2 Argentina Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

13.4.3 Columbia Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

13.4.4 Chile Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

13.4.5 Venezuela Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

13.4.6 Peru Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

13.4.8 Ecuador Oncolytic Virus Therapy Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Oncolytic Virus Therapy Business

14.1 Amgen

14.1.1 Amgen Company Profile

14.1.2 Amgen Oncolytic Virus Therapy Product Specification

14.1.3 Amgen Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 SillaJen Biotherapeutics

14.2.1 SillaJen Biotherapeutics Company Profile

14.2.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Specification

14.2.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Transgene SA

14.3.1 Transgene SA Company Profile

14.3.2 Transgene SA Oncolytic Virus Therapy Product Specification

14.3.3 Transgene SA Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Oncolytics Biotech

14.4.1 Oncolytics Biotech Company Profile

14.4.2 Oncolytics Biotech Oncolytic Virus Therapy Product Specification

14.4.3 Oncolytics Biotech Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 PsiOxus Therapeutics

14.5.1 PsiOxus Therapeutics Company Profile

14.5.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Specification

14.5.3 PsiOxus Therapeutics Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Viralytics

14.6.1 Viralytics Company Profile

14.6.2 Viralytics Oncolytic Virus Therapy Product Specification

14.6.3 Viralytics Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Lokon Pharma

14.7.1 Lokon Pharma Company Profile

14.7.2 Lokon Pharma Oncolytic Virus Therapy Product Specification

14.7.3 Lokon Pharma Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Targovax

14.8.1 Targovax Company Profile

14.8.2 Targovax Oncolytic Virus Therapy Product Specification

14.8.3 Targovax Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Oncolys BioPharma

14.9.1 Oncolys BioPharma Company Profile

14.9.2 Oncolys BioPharma Oncolytic Virus Therapy Product Specification

14.9.3 Oncolys BioPharma Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Sorrento Therapeutics

14.10.1 Sorrento Therapeutics Company Profile

14.10.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Specification

14.10.3 Sorrento Therapeutics Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Genelux Corporation

14.11.1 Genelux Corporation Company Profile

14.11.2 Genelux Corporation Oncolytic Virus Therapy Product Specification

14.11.3 Genelux Corporation Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Cold Genesys

14.12.1 Cold Genesys Company Profile

14.12.2 Cold Genesys Oncolytic Virus Therapy Product Specification

14.12.3 Cold Genesys Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Vyriad

14.13.1 Vyriad Company Profile

14.13.2 Vyriad Oncolytic Virus Therapy Product Specification

14.13.3 Vyriad Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 TILT Biotherapeutics

14.14.1 TILT Biotherapeutics Company Profile

14.14.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Specification

14.14.3 TILT Biotherapeutics Oncolytic Virus Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Oncolytic Virus Therapy Market Forecast (2022-2027)

15.1 Global Oncolytic Virus Therapy Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Oncolytic Virus Therapy Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Oncolytic Virus Therapy Value and Growth Rate Forecast (2022-2027)

15.2 Global Oncolytic Virus Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Oncolytic Virus Therapy Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Oncolytic Virus Therapy Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Oncolytic Virus Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Oncolytic Virus Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Oncolytic Virus Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Oncolytic Virus Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Oncolytic Virus Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Oncolytic Virus Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Oncolytic Virus Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Oncolytic Virus Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Oncolytic Virus Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Oncolytic Virus Therapy Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Oncolytic Virus Therapy Consumption Forecast by Type (2022-2027)

15.3.2 Global Oncolytic Virus Therapy Revenue Forecast by Type (2022-2027)

15.3.3 Global Oncolytic Virus Therapy Price Forecast by Type (2022-2027)

15.4 Global Oncolytic Virus Therapy Consumption Volume Forecast by Application (2022-2027)

15.5 Oncolytic Virus Therapy Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology